Enhancing Children’s Cancer Diagnosis at QECH: A Transformative Donation
A new chemistry analyzer donated by NBM plc has significantly reduced the time needed to diagnose childhood cancers at QECH in Malawi, enhancing care for patients. Former delays due to limited equipment are now alleviated, allowing healthcare providers to deliver rapid and accurate results. The ongoing need for additional resources remains, emphasizing the importance of continuous improvement in healthcare services.
The prospect of receiving news that one’s child is to undergo a cancer diagnosis at Queen Elizabeth Central Hospital (QECH) can be a daunting experience. Typically, the diagnosis process takes one to two days as the facility has a single machine designated for this purpose. In some instances, children may need to repeat the procedure due to the alleged loss of the first sample, causing parents considerable distress as they witness their child’s deteriorating health while awaiting results.
Prior to the acquisition of a chemistry analyzer donated by the National Bank of Malawi (NBM) plc in 2023, many families faced lengthy waits at the Child Cancer Ward. The donation has revolutionized the diagnosis process by facilitating early detection with accurate results, thereby reducing the average time for tests to one to two hours. Common types of cancer affecting children in Malawi include Leukemia, Burkitt Lymphoma, Wilms tumor, Retinoblastoma, and Non-Hodgkin Lymphoma.
QECH records approximately 500 childhood cancer diagnoses annually, resulting in an average of 20 to 30 new patients each month. Last year, in February, the Children’s Cancer Ward marked World Cancer Day, having made 264 diagnoses since the introduction of the analyzer. Dr. Beatrice Chikaphonya Phiri, a Pediatric Oncologist, emphasized the significance of the analyzer for their operations, stating that it allows them to obtain results much faster than before, which is essential for patient care.
The ability to generate timely results has markedly improved treatment protocols, according to Dr. Chikaphonya Phiri. Previously, samples would be sent to the central lab, causing delays, particularly due to reagent shortages. Now, results are obtained nearly immediately, ensuring that patient care reflects their current health status. Dr. Chikaphonya Phiri expressed gratitude for this advancement, having processed 550 samples using the chemistry analyzer with minimal repetitions of tests.
Dr. Nthambose Simango, Pediatrics Department Registrar, supports the improvements facilitated by the new machinery. She noted that the previous setup hindered their ability to conduct necessary tests promptly. Having consistent access to lab results now allows for better management of patients year-round. However, she also highlighted the ongoing needs, such as a mobile X-ray machine to assist with patients who cannot be transported easily for traditional X-ray procedures.
George Jobe, Executive Director of the Malawi Health Equity Network (MHEN), highlighted that advancements in equipment are critical to healthcare progression. The presence of modern technological tools contrasts sharply with the limitations faced two decades ago. This improvement signifies a positive trajectory in the medical field, enhancing the working life of healthcare professionals.
Akossa Hiwa, Marketing and Corporate Affairs Manager at NBM plc, reaffirmed the bank’s commitment to impactful Corporate Social Investment initiatives. She expressed satisfaction in the contributions made towards enhancing health outcomes for Malawian children through the donation of the chemistry analyzer. Each investment aims to create sustainable benefits, embodying the theme, ‘United by Unique’, which emphasizes the importance of collective efforts in addressing cancer care needs.
The introduction of a chemistry analyzer at QECH has substantially improved the speed and accuracy of cancer diagnoses for children in Malawi. With this advancement, healthcare providers can offer timely and effective treatments, greatly enhancing patient outcomes. Continued investments and improvements in medical technology are essential for further progress in the healthcare system, ensuring equitable care for all patients.
Original Source: www.nyasatimes.com
